Dow Up 1.63% Nasdaq Up 0.97%

More On MBLTY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Mesoblast Limited (MBLTY)

-Other OTC
17.74 1.44(8.83%) Oct 17, 1:01PM EDT
|Pre-Market : NaN
Prev Close:16.30
Open:17.27
Bid:N/A
Ask:N/A
1y Target Est:12.35
Beta:N/A
Next Earnings Date:N/A
Day's Range:17.27 - 17.75
52wk Range:16.20 - 31.60
Volume:900
Avg Vol (3m):1,737
Market Cap:1.13B
P/E (ttm):N/A
EPS (ttm):-1.11
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):34.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.69
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Mesoblast Limited, a biotechnology company, is engaged in the research and development of its propriety stem cell technologies for use in the treatment of multiple major disease states and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback